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Abstract
Objectives The aims of this study were to: (1) describe
alcohol industry corporate social responsibility (CSR)
actions conducted across six global geographic regions;
(2) identify the benefits accruing to the industry (‘doing
well’); and (3) estimate the public health impact of the
actions (‘doing good’).
Setting Actions from six global geographic regions.
Participants A web-based compendium of 3551 industry
actions, representing the efforts of the alcohol industry
to reduce harmful alcohol use, was issued in 2012. The
compendium consisted of short descriptions of each
action, plus other information about the sponsorship,
content and evaluation of the activities. Public health
professionals (n=19) rated a sample (n=1046) of the
actions using a reliable content rating procedure.
Outcome measures WHO Global strategy target area,
estimated population reach, risk of harm, advertising
potential, policy impact potential and other aspects of the
activity.
Results The industry actions were conducted
disproportionately in regions with high-income countries
(Europe and North America), with lower proportions in
Latin America, Africa and Asia. Only 27% conformed
to recommended WHO target areas for global action to
reduce the harmful use of alcohol. The overwhelming
majority (96.8%) of industry actions lacked scientific
support (p<0.01) and 11.0% had the potential for doing
harm. The benefits accruing to the industry (‘doing well’)
included brand marketing and the use of CSR to manage
risk and achieve strategic goals.
Conclusion Alcohol industry CSR activities are unlikely
to reduce harmful alcohol use but they do provide
commercial strategic advantage while at the same time
appearing to have a public health purpose.

Introduction
Corporate social responsibility (CSR) refers
to business practices that help companies
manage their economic, social and environmental impacts, and their relationships in
key areas of influence, such as the marketplace, the supply chain, the community and
the public policy arena.1 2 The notion that

Strengths and limitations of this study
►► Use of a global database of industry activities that

is likely to be comprehensive and representative of
the alcohol industry’s corporate social responsibility
activities.
►► A 30% sample was selected from the International
Alliance for Responsible Drinking database. Different
conclusions may have resulted with a larger sample.
►► Unable to determine whether the industry actions
represented significant charitable contributions or
were merely activities that in some cases would
have been conducted anyway (eg, those required
by law).
►► Although all raters were initially trained to an acceptable level of reliability, we cannot rule out differential bias in the raters recruited from different
regions.

commercial enterprises can ‘do well’ (eg,
improve their brand image, increase their
profitability) by ‘doing good’ (ie, contribute
to socially beneficial groups and causes)
has motivated this rapidly expanding global
movement.3 4 While the motives behind CSR
vary, they appear to be indirectly related
to the financial performance of corporations.5 6 CSR has been described as one of
the few remaining strategies for unhealthy
commodity industries (eg, tobacco, alcohol,
gambling) to present their products in a positive light and thereby improve their reputations.7 8 Evidence indicates that the tobacco
industry used CSR activities to improve their
image, deflect criticism, enable access to
policy makers and mitigate legal risks, thereby
increasing profits.7 9–11 Despite a substantial amount of published research that has
questioned the motives of the alcohol industry’s CSR activities,12–15 little is known about
the characteristics of these activities or their
impact on public health.16
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exported from the website’s print view from August 2013
to August 2015 prior to the database being shut down
without explanation in April 2016. Actions were sorted by
region according to the geoscheme created by the United
Nations Statistics Division (UNSD), and then alphabetically by action title. Units were selected so that the
sampling strata maintained the proportions of the ‘target
population,’ which in this case is the total number of
industry actions (n=3551). This means that each stratum
(UNSD geographic region) has the same sampling fraction. Using data from two countries (USA and UK) and
one region (Latin America and the Caribbean) where all
industry actions were rated, we determined that a proportionate sample size of 30% provided an accurate estimate
of the actual distribution. The random sample generator
function in SPSS Windows V.24 was used to select the 30%
sample from each United Nations (UN) region and those
labelled by ICAP/IARD as ‘international’ or ‘global’
(n=1046).

Methods
From 2014 until 2016, 19 trained raters from Brazil, Argentina, the USA, the European Union (EU) and Australia
analysed a sample of 1046 industry actions. Data were

Measures of industry benefits (‘doing well’)
Each industry action was coded for marketing potential.
If the action involved giving away promotional materials
or marketed a specific product, it was coded as having

2

Descriptive measures
An evidence benchmarking protocol was used to extract
information on the sponsoring organisation, partners,
year started, country and industry-reported evaluation
(if applicable) for each industry action sampled from the
database. Based on the short qualitative summaries of the
actions (mean words per action=132) provided on the
website, we assigned numeric codes for the type of partners listed (eg, government, non-governmental organisation, SAPRO, trade association, etc.) and for the type of
evaluation reported by the industry (process evaluation,
uncontrolled outcome evaluation, controlled outcome
evaluation or ‘does not meet the minimum criteria’).
We used country names to define geographic regions
following the UNSD classification of geographic regions
(eg, Africa, Asia) and subregions (eg, Latin America and
the Caribbean) (https://unstats.un.org/unsd/methodology/m49/) and the World Bank database (https://data.
worldbank.org/country) to define country income-level.
Estimated population reach refers to the number of
people in the target group that could be served when
an intervention is provided under real-world conditions.
Coding options were none, small, moderate and large.
This variable is relative and was coded after raters were
trained using model scenarios. For example, if the action
was implemented across the entire USA, but only reached
10 000 people, it was coded as small.
In addition to these descriptive characteristics of the
industry actions, we also coded whether the activity was
likely to produce benefits to the alcohol industry, and
the ways in which society in general would benefit (or be
harmed). These variables and their operational definitions are described in table 1.
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The alcohol industry has invested significant resources
to promote CSR initiatives around the world. In what is
perhaps the largest initiative of its kind, on 9 October
2012, 11 major global producers of alcoholic beverages and two major trade associations issued a set of
‘Producers’ Commitments’ to reduce harmful drinking
(http://www.producerscommitments.org/default.aspx).
To illustrate the industry’s efforts to fulfil these commitments, an industry-sponsored database (initially posted at
initiatives.global-actions.org, but subsequently removed)
was created by the International Centre for Alcohol Policies (ICAP), now called the International Alliance for
Responsible Drinking (IARD). The database was an inventory of over 3500 industry actions conducted in support
of the WHO Global strategy to reduce the harmful use
of alcohol (Global strategy).17 The Global strategy is a
menu of 10 evidence-based policy options that the WHO
member states can use to achieve reductions in harmful
alcohol use. Contributors to the industry-supported database included multinational producers of beer, wine and
distilled spirits; alcohol distributors and wholesalers;
members of related industries, such as hotels, restaurants,
bars and advertisers; and industry-affiliated social aspect
and public relations organisations (SAPROs).
The present study had three aims: (1) to describe the
global distribution of the industry actions according to
geographic regions and high-resource and low-resource
areas; (2) to estimate the benefits accruing to the industry
in terms of marketing potential, impact on regulatory
policy and type of CSR strategy; and (3) to evaluate the
public health impact of the industry actions in terms of
their likely effectiveness and potential harm. We were
particularly interested in the extent to which the industry’s actions conformed to options recommended by
WHO and the evidence base that informed the Global
strategy. This is the first comprehensive analysis of the
3500 industry actions posted on the ICAP/IARD website.
Analyses of the drinking and driving initiatives18 and the
marketing potential of the initiatives conducted in Latin
America and the Caribbean15 have been published in
prior reports.
Considering the significant contribution alcohol makes
to global disease burden,17 this study evaluated whether
the Global Producers’ actions reflect evidence-based
approaches likely to reduce alcohol harm, or whether
they are mainly conducted as a form of ‘stakeholder
marketing’19 designed to produce favourable public
perceptions and less restrictive regulatory environments.
To answer this question, we conducted a systematic evaluation of a sample of the industry actions using a content
rating procedure designed to evaluate their public health
implications and commercial benefits.

Open access

Measurement domain

Variable name

What is measured

Industry benefit measures
(‘Doing well’)

Marketing/advertising
potential

Whether the action has the
None; possible
potential to promote a specific
brand or product.
Whether the action has the
None; possible
potential to impact national or local
policy

Policy impact potential

Societal benefit measures
(‘Doing good’)

Coding options

CSR type

Likely operational impact rather
than presumed motivation of
industry actor

None, strategic, risk management,
altruistic

WHO Global strategy
target area

Whether the action covers one of
the 10 target areas recommended
by the WHO Global strategy

0=Not consistent with any Global
strategy area
1–10=consistent with one of the 10
Global strategy areas
11=too vague to classify

Activity type

Whether the action fit a list of 67
interventions, programmes and
policies that have been evaluated in
prior research for effectiveness

Choice of 79 activity types, of
which 67 have been evaluated and
12 ‘other’ types which had not
been subjected to research

Evidence of
effectiveness

Estimate its potential for reducing
alcohol-related harm based on the
scientific literature

Risk of harm potential

Whether the action had the
potential to cause harm or damage
based on available evidence

Activity types were coded as
follows:
0=evidence indicates a lack of
effectiveness
1=evidence for limited effectiveness
2=evidence for moderate
effectiveness
3=evidence of a high degree of
effectiveness
9=no studies have been undertaken
or there is insufficient evidence on
which to make a judgement
None; possible

‘possible’ marketing potential. Actions that did not meet
this criterion and all activities undertaken by trade organisations or SAPROs were rated as having no marketing
potential.
The policy impact potential of each action (ie, whether
the action had the potential to impact national or local
policy) was coded as ‘none’ or ‘possible’. We coded only
activities that had a clear political or policy impact as
‘possible’.
The type of CSR was coded based on previously
published definitions.20 Coding options were ‘none’—not
having a social or environmental responsibility interpretation or not reflecting positively on the company; ‘altruistic’—responsibilities that reflect giving back time or
money to contribute solely to the well-being of a community or society at the possible expense of the business;
‘risk management’—legal or ethical obligations that are
socially required; or ‘strategic’—aimed at achieving business goals while also promoting societal welfare. Coders
were provided with examples and indicators for each type
of CSR to minimise subjective bias.
Babor TF, et al. BMJ Open 2018;8:e024325. doi:10.1136/bmjopen-2018-024325

Societal benefit measures (‘doing good’)
Raters assessed whether the initiative fit into any of the
10 WHO Global strategy target areas. If a clear match was
not possible, based on descriptions in the WHO17 Global
strategy, the initiative was coded as either ‘not classifiable’
because of insufficient information, or ‘not compatible
with any of the ten categories.’
Activity type was coded for each action in order to identify actions that had evidence of effectiveness.21 Activities were coded according to a list of 67 interventions,
campaigns, programmes and policies that had been evaluated in prior research for effectiveness.21 Actions that
did not fit these activity types were coded as ‘other’, which
had 12 subcodes. These included administrative changes
by a particular company, online media campaigns, industry-sponsored research, conference sponsorships, information for parents, promotional events and activities
unrelated to reducing the harmful use of alcohol, such as
scholarships for students being trained in the hospitality
industry.
3
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Table 1 Measurement domains, variables measured and coding options used in content analysis of alcohol industry
corporate social responsibility activities

Open access

Training of raters
Nineteen public health professionals with expertise in
alcohol control policy from Latin America (9), USA (3),
the EU (5) and Australia (2) analysed the industry actions
within their respective regions. A rater training workshop
was conducted by the protocol authors with each regional
team prior to the start of the global project to ensure
consistency. After the raters were trained at regional
sites using a standardised protocol, they each rated the
same 35 randomly selected actions from the database,
compared their ratings to the ratings of the protocol
authors and discussed discrepancies with experts until
consensus was achieved. A second round of another 35
randomly selected initiatives was then conducted. After
achieving an acceptable level of inter-rater reliability
(kappa >0.60), the raters continued rating the remaining
actions independently.
Statistical analyses
Data was analysed using SPSS for Windows V.24
(Armonk, New York, USA: IBM Corp.). Omnibus χ2 tests
were used to determine significant differences in variables that were dichotomous (eg, marketing potential)
or categorical (eg, sponsoring organisations) across UN
geographic regions that conformed approximately to
the WHO regions used for administrative and statistical
purposes.
Significance was set at p<0.05. To understand the
meaning of a significant omnibus test, several logistic
regressions were used. In each model, a single UN
region was compared against the rest of the world for
a specific dependent variable. For instance, the prevalence of industry actions that had marketing potential in Africa was compared against the prevalence of
industry actions with marketing potential in all other
UN regions combined. Statistical significance was determined using 95% CIs of the resultant ORs. This method
allowed for increased interpretability of the results,
while limiting the impact of type I error, which would
have been a serious concern had pairwise comparisons
been implemented. χ2 tests and Spearman correlations were also used to determine whether population
reach was correlated with marketing potential and
effectiveness.
4

Results
Table 2 presents descriptive information about the
actions. More than half of the actions were conducted
in Europe (57.7%), and 76% were based in high-income
countries (HICs). Less than 8% of actions were conducted
in lower-middle and low-income countries. Despite the
claims of ICAP/IARD that the actions were conducted
‘in support of’ the Global strategy,17 most (65.7%) were
initiated prior to the 2010 release of the Global strategy,
and some (10.4%) prior to 2000, according to the dates
provided in the listings.
Doing well: benefits accruing to the industry
The first three sections of table 3 show the regional
percentages, ORs and CIs of three benefits accruing to
the alcohol industry. Overall, 26.5% of the actions were
rated as having a marketing potential, 15.2% had the
potential to have a policy impact and 18.0% were classified as having a ‘strategic’ CSR function. The proportion
of actions that were considered to have one or more of
these benefits was 46.0%.
Activities coded as having a marketing potential
included giving away branded merchandise and adding a
responsible drinking message to the product’s commercial
advertising materials. There were significant differences
in industry actions that contained marketing potential
across UN regions (χ2 = 47.44; df=6; p<0.01). Actions
conducted in Latin America and Africa were significantly
more likely to have marketing potential compared with
actions conducted in all other regions (table 3). Actions
conducted in Oceania had a significantly lower likelihood
of marketing potential.
We also evaluated the association between estimated
population reach and marketing potential. Of the 277
actions with marketing potential, 44.4% had moderate
to large population reach (χ2 = 29.31; df=1; p<0.01).
The Spearman correlation indicated a positive association, which was statistically significant (rs(1046)=0.158, p
=<0.01).
Fifteen per cent (15.2%) of actions were found to have
the potential to influence policies, for example, sponsoring of a traffic safety council or conducting workshops
for policy makers (table 3). Actions with policy potential
differed significantly among regions (χ2 = 26.58; df=6;
p<0.01). Actions in Africa, Oceania and those conducted
on an international scale were considered more likely to
have a policy impact.
Regarding the type of CSR, the majority of sampled
actions (77.4%) were coded as ‘risk management’
(eg, ‘responsible drinking message added to labels’)
while 18.0% were coded as strategic CSR (eg, a conference promoting self-regulation of alcohol advertising)
(table 3). The number of actions categorised as having
a strategic CSR approach was significantly different
across regions (χ2 = 36.15; df=6; p<0.01). A strategic
CSR approach was more likely to be used on an international scale and in the African Region. Actions in North
America were less likely to take a strategic CSR approach.
Babor TF, et al. BMJ Open 2018;8:e024325. doi:10.1136/bmjopen-2018-024325
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Evidence of effectiveness was coded from the public
health perspective21 22 by assigning scores to each coded
activity to estimate its potential for reducing alcohol-related harm: 0=lack of effectiveness; 1=limited effectiveness; 2=moderate effectiveness; 3=high degree of
effectiveness; 9=no studies have been undertaken or there
is insufficient evidence on which to make a judgement.
Harm potential was also assessed for each action. If an
action was considered likely to pose a risk of harm based
on current theory or evidence, harm potential was coded
as ‘possible’. Raters were instructed to code harm potential very conservatively, based on the available evidence.

Open access

n (%)
Region*
 Africa

69 (6.6)

 Asia

63 (6.0)

 Europe

604 (57.7)

 Latin America

67 (6.4)

 North America

163 (15.6)

 Oceania

40 (3.8)

 International

40 (3.8)

Country income level†
 High

797 (76.2)

 Upper-middle

127 (12.1)

 Lower-middle

59 (5.6)

 Low

22 (2.1)

 Multiple

41 (3.9)

Year started‡
 1990–1999

105 (10.4)

 2000–2009

559 (55.3)

 2010–2014

346 (34.2)

Estimated population reach
 None

218 (20.8)

 Small

499 (47.7)

 Moderate

218 (20.8)

 Large

111 (10.6)

Sponsor
 Producer

537 (51.3)

 SAPRO

306 (29.3)

 Trade association

182 (17.4)

 Other

21 (2.0)

Partner
 None reported

509 (48.7)

 Governmental

64 (6.1)

 NGO/University

92 (8.8)

 SAPRO/Trade association

55 (5.3)

 Commercial

65 (6.2)

 Multiple partner types
 ‘Non specified collaborator’/Other

170 (16.3)
91 (8.7)

Industry-reported evaluation
 None reported
 Does not meet minimum criteria
 Process
 Outcome

688 (65.7)
92 (8.8)
217 (20.7)
49 (4.7)

*Regions according to United Nations Statistics Division
classifications.
†According to World Bank classifications.
‡n=1010 because of missing data.
NGO, non-governmental organisation; SAPRO, social aspect and
public relations organisation.
Babor TF, et al. BMJ Open 2018;8:e024325. doi:10.1136/bmjopen-2018-024325

Less than 2% (1.6%) of actions were coded as altruistic
type CSR. Three per cent of actions were coded as not
fitting any CSR approach.
Doing good: public health impact of the industry actions
Table 4 shows the regional percentages, ORs and CIs
of industry actions that were consistent with the WHO
Global strategy targets. Overall, only 27.1% were considered classifiable into the WHO target areas, which was
significantly different between UN regions (χ2 = 34.68;
df=6; p<0.01). Actions in Africa and North America were
more likely to fall under one of the 10 Global strategy
target areas, although the majority of actions remained
inconsistent with the Global strategy.
Figure 1 compares the proportions classified into
the 10 WHO Global strategy areas by the public health
raters with those classified by the industry and reported
on the ICAP/IARD website. The table shows substantial
discrepancies between the proportions assigned to three
key areas: leadership (22.3% ICAP/IARD vs 3.0% public
health raters), drinking and driving initiatives (28.7% vs
14.1%) and reducing negative consequences (27.4% vs
3.6%). The main reason for these discrepancies was that
the public health raters, using WHO definitions of the
target areas, were not able to classify 72.9% of the actions
into any of the 10 categories, either because they clearly
did not fit the definitions (39.3%) or they were too vague
(33.6%).
In addition to the ratings based on the WHO
target areas, separate ratings were conducted to classify
the specific type of activity and to estimate its potential
effectiveness. Table 5 shows how the actions were classified according to activity type and evidence for effectiveness. The majority of actions (75.9%) were coded ‘other’
activity types which have not been evaluated in the literature. Activities coded here include posters, leaflets and
websites, industry-sponsored conferences, funding of
SAPRPOs and updates to producer employee handbooks.
Each activity code was assigned an effectiveness score
based on expert consensus ratings.21 22 Since there were
only 33 actions coded as limited, moderate or high effectiveness, these three categories were collapsed. There
were considerably more ineffective actions or actions of
unknown effectiveness (96.8%) compared with effective actions overall (p<0.01). Nearly half of the actions
(46.8%) were activities that have not been evaluated in
the research. Over 20% (21.0%) were activities that were
not relevant to public health (ie, funding of SAPROs).
Twenty-nine per cent of the actions have been evaluated
in the alcohol literature21 and have been found not to
be effective; 1.3% were found to have limited effectiveness. Only 1.8% of total activities sampled had evidence
of moderate to high effectiveness (eg, minimum legal
alcohol purchase age).
Another part of the content ratings focused on
the potential of the action to cause harm (eg, using
the Grand Prix racing event to launch an awareness
campaign). Eleven per cent of actions were found to have
5
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Table 2 Characteristics of industry actions to reduce
harmful drinking online compendium (n=1046)
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Marketing potential

Policy impact

Strategic CSR actions

Region*

%

OR†

95% CI

%

OR†

95% CI

%

OR†

95% CI

Africa (n=69)
Asia (n=63)

43.5
15.9

3.08
0.50

1.24 to 7.64
0.25 to 1.00

29.0
6.9

2.46
1.19

1.41 to 4.26
0.60 to 2.34

33.3
20.6

2.45
1.77

1.45 to 4.16
0.87 to 3.61

Europe (n=604)

24.0

0.74

0.56 to 0.97

13.9

0.79

0.56 to 1.10

15.2

0.64

0.47 to 0.89

LAC (n=69)

53.7

4.65

1.87 to 11.56

7.5

0.43

0.17 to 1.09

22.4

1.34

0.73 to 2.44

North America (n=163)

27.0

1.03

0.70 to 1.50

10.4

0.6

0.35 to 1.03

11.0

0.52

0.31 to 0.87

Oceania (n=40)

10.0

0.29

0.10 to 0.84

27.5

2.19

1.07 to 4.98

27.5

1.77

0.87 to 3.61

International (n=40)
Totals (n=1046)

33.3
26.5

0.68
–

0.31 to 1.50
–

27.5
15.2

2.19
–

1.07 to 4.98
–

40.0
18.0

3.22
–

1.67 to 6.19
–

*Regions based on United Nations Statistics Division classifications.
†United Nations region compared with the rest of the world.
LAC, Latin America and Caribbean.

the potential to cause harm from a public health perspective, which was significantly different across regions (χ2
= 32.98; df=6; p<0.01). Actions that had a potential for
harm were most likely to occur in Latin America and the
Caribbean (LAC) and Oceania and were least likely to
occur in North America (table 4).
Discussion
The present analysis of CSR activities conducted by alcohol
industry bodies ostensibly in support of the WHO’s Global
strategy adopted a perspective that contrasted public health
interests with the commercial interests of the alcohol
industry. While the actions were found to be conducted
disproportionately in HICs of Europe and North America,
actions in Africa and LAC were found to be significantly associated with an increased likelihood for marketing potential.
This is consistent with research suggesting that competitive
industries that depend on marketing to sell their products
are more likely to include product marketing in their CSR
activities,3 and that the large producers are targeting developing countries.23 24 The positive association found between

marketing potential and population reach provides further
indication that industry segments may be using the industry
actions for marketing purposes.
Regarding the benefits accruing to the alcohol industry
(‘doing well’), our analyses show that the industry’s CSR
activities tend overwhelmingly to be oriented towards
risk management and achieving strategic goals. Research
suggests that industry-funded educational campaigns lead
to positive views of that industry.25 As Bond, Daube and
Chikritzhs26 note, alcohol industry documents further
demonstrate the public relations benefit of ‘responsibility’
messages and education campaigns.
Although alcohol industry bodies promoted the online
inventory as a reflection of their commitments to the WHO
2010 Global strategy, 72.9% of the industry actions we evaluated were scored as not conforming to the WHO recommended target categories. Some activities (eg, a brewery’s
60th anniversary celebration) seemed to contradict the
intent of the Global strategy and were seemingly inconsistent with the stated purpose of the alcohol industry actions.
There were also major differences between the industry’s

Table 4 Percentage, ORs and 95% CIs of actions rated as meeting WHO Global strategy target areas and actions with
potential for harm, by region (n=1046)
WHO Global strategy target area met

Potential for harm

Region*

%

OR†

95% CI

%

OR†

95% CI

Africa (n=69)
Asia (n=63)

39.1
23.8

1.81
0.83

1.09 to 2.99
0.45 to 1.51

7.2
15.9

0.61
1.57

0.24 to 1.56
0.77 to 3.19

Europe (n=604)

24.8

0.76

0.58 to 1.01

9.6

0.71

0.48 to 1.05

LAC (n=69)

32.8

1.34

0.79 to 2.28

25.4

3.05

1.69 to 5.50

North America (n=163)

38.7

1.89

1.38 to 2.69

6.1

0.48

0.24 to 0.94

Oceania (n=40)
International (n=40)

7.5
10.0

0.21
0.21

0.06 to 0.68
0.06 to 0.68

27.5
10.0

3.29
0.89

1.59 to 6.78
0.31 to 2.56

*Regions based on United Nations Statistics Division classifications.
†United Nations region compared with the rest of the world.
LAC, Latin America and Caribbean.
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Table 3 Percentages, ORs and 95% CIs by region for marketing potential, potential policy impact and strategic corporate
social responsibility (CSR)

Open access

classification of their own actions and those conducted by the
expert raters. Whereas ICAP/IARD classified most (75%) of
the actions under the areas of leadership, drinking-driving
countermeasures and reducing negative consequences, the
raters found that almost one-third were too vague to classify
and another 38% did not fit any of the WHO categories. As
an industry-funded SAPRO, ICAP/IARD had a clear conflict
of interest that could have biased their interpretation of
the actions, as had been demonstrated in prior analyses of
their international activities.27 28 Of note, most of the actions
had start dates before the WHO Global strategy was issued,
raising questions about the screening process used and the
aims of the database.
Estimates of the public health benefits and harms showed
that the overwhelming majority (96.8%) of industry actions
lacked scientific support of their effectiveness in reducing
harmful drinking and a small percentage (11.0%) had the
potential for doing harm. The Guidelines on Implementation of Articles 5 and 13 of the WHO Framework Convention on Tobacco Control propose a ban on all contributions
from tobacco companies to any other entity for ‘socially

responsible’ causes as ‘the aim, effect, or likely effect…is
to promote…(the) product or use, either directly or indirectly’.29 Our analysis suggests that a similar ban would be
appropriate for the alcohol industry. This caveat was reiterated by then WHO Director General Margaret Chan in her
statement that alcohol companies should have ‘no role in
the formulation of alcohol policies, which must be protected
from distortion by commercial or vested interests’.30
One strength of this study is its use of a global database
of industry activities that is likely to be comprehensive and
representative of the alcohol industry’s CSR activities. Our
analysis indicates that those activities contribute minimally
to the public health efforts of the WHO. This research also
had some methodological limitations. Because of resource
limitations, we evaluated only a sample from the IARD database. Different conclusions may have resulted with a larger
sample. In addition, we were not able to estimate the costs to
the industry of the actions conducted to determine whether
they represented significant charitable contributions or
were merely activities that in some cases would have been
conducted anyway (eg, staff training at breweries or actions

Table 5 Activity type by level of effectiveness (n=1046)
Evidence of effectiveness
Activity type (example)

N

None/Unknown

Limited–moderate

Availability (MLPA, different availability by strength)
Environment (RBS training)

7
49

0.0
4.0

0.7
0.7

Drink-driving (designated driver campaigns, safe rides)

49

4.6

0.1

Brief intervention and treatment

5

0.0

0.5

Marketing (self-regulation codes)

67

6.2

0.2

Education and persuasion

75

6.1

1.1

‘Other’ (newsletters, industry-sponsored conferences)
Total

794
1046

75.9
96.8%

0.0
3.2%

MLPA, minimum legal purchase age; RBS, responsible beverage service.
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Figure 1 Percent of industry actions classified by International Alliance for Responsible Drinking and by health professionals
according to WHO Global strategy target areas.

Open access

Conclusion
This analysis provides a window into the CSR activities
considered by the alcohol industry to have relevance to their
response to the WHO Global strategy. The magnitude and
global scope of these initiatives speaks to the ability of the
alcohol industry to mobilise its diverse commercial components in pursuit of a common cause, much like the tobacco
industry did before them. Far from confirming industry
claims that they can ‘do well’ by ‘doing good,’ the findings
of the present study suggest that the public health benefits
of their CSR activities are likely to be minimal, whereas the
public relations benefits can be substantial.
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which are already required by law). Although raters were all
trained to an acceptable level of reliability, we cannot rule
out differential bias in the raters recruited from different
regions.

